NCT04407442: Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab |
|
|
| Terminated | 2 | 5 | US | Azacitidine, 5 AZC, 5-AC, 5-Azacytidine, 5-AZC, Azacytidine, Azacytidine, 5-, Ladakamycin, Mylosar, U-18496, Vidaza, Daratumumab, Anti-CD38 Monoclonal Antibody, Darzalex, HuMax-CD38, JNJ-54767414, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex | University of California, San Francisco, Janssen Pharmaceuticals, Multiple Myeloma Research Foundation | Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | 04/23 | 04/23 | | |
NCT05191472: Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies |
|
|
| Terminated | 2 | 3 | US | Pembrolizumab, Keytruda, Lambrolizumab, MK-3475 | Alfred Chung, MD, Merck Sharp & Dohme LLC | Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | 12/23 | 12/23 | | |
ALTITUDE, NCT05486481: Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) |
|
|
| Recruiting | 1/2 | 46 | US | Venetoclax, Venclexta, Dexamethasone, Ozurdex, Daratumumab, Darzalex, Daratumumab SC, Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence in situ hybridization (FISH) assay | Alfred Chung, MD, Janssen Pharmaceuticals, AbbVie | AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease | 12/27 | 12/27 | | |
